CSN Login
Members Online: 18

Vaccine for prostate cancer?

Kentr
Posts: 111
Joined: May 2009

I just heard a bit on the radio about a vaccine for prostate cancer that is likely to be approved by the FDA this week. Apparently it's administered in the same way as dyalisis. They didn't name the drug so I can't provide any illuminating info. They did say it would cost somewhere around $70K. Has anyone else heard of this and/or have more info? DANG, I just KNEW something like this would happen AFTER I had brachytherapy - LOL

Kongo's picture
Kongo
Posts: 1167
Joined: Mar 2010

I believe the vaccine you are referring to is Provenge, a customized drug that several on this post have discussed. As I understand it, Provenge is designed to prolong life and retard cancer for those with advanced stages.

lewvino's picture
lewvino
Posts: 1007
Joined: May 2009

I googled and found this article: http://www.cbsnews.com/stories/2010/04/26/earlyshow/health/main6433211.shtml

It sounds like it is for 'advanced cases' of prostate cancer and extends life for about 4 months in the studies done. So save your $70k and don't spend it!

Perhaps though it will lead to other findings.

Larry

erisian's picture
erisian
Posts: 109
Joined: Dec 2008

The vaccine expecting FDA approval 'Real Soon Now' is indeed Provenge (sipuleucel-T)

It has only been tested against advanced prostate cancer.
There are some links in this thread:
http://csn.cancer.org/node/188308

Lead to something? No, this IS something! It will be the first "active immunotherapy" to be FDA approved for the treatment of cancer.
The 4.1 month increase in median survival may not sound like much, but it is the largest increase ever seen in a phase 3 trial for any treatment for advanced prostate cancer. Other numbers from the studies showed an increase in 36-month survival from 21% to 32%, a 50% increase. That's not a trivial increase from my perspective.

From: http://www.nature.com/news/2010/100421/full/4641110a.html
"The vaccine is tailor-made for each patient by harvesting his dendritic cells — a type of immune cell — and exposing them to a cancer-associated protein called prostatic acid phosphatase. Once infused back into the patient, the exposed cells should trigger an immune assault on tumour cells."

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2014 © Cancer Survivors Network